Merck & Co Inc (MRK)
131.20
+0.48
(+0.37%)
USD |
NYSE |
Apr 26, 16:00
131.15
-0.05
(-0.04%)
After-Hours: 20:00
Merck Revenue (TTM): 61.40B for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 61.40B |
| December 31, 2023 | 60.11B |
| September 30, 2023 | 59.31B |
| June 30, 2023 | 58.31B |
| March 31, 2023 | 57.87B |
| December 31, 2022 | 59.28B |
| September 30, 2022 | 58.97B |
| June 30, 2022 | 57.17B |
| March 31, 2022 | 53.98B |
| December 31, 2021 | 48.70B |
| September 30, 2021 | 46.13B |
| June 30, 2021 | 43.91B |
| March 31, 2021 | 41.86B |
| December 31, 2020 | 43.29B |
| September 30, 2020 | 36.49B |
| June 30, 2020 | 37.96B |
| March 31, 2020 | 40.36B |
| December 31, 2019 | 39.12B |
| September 30, 2019 | 45.97B |
| June 30, 2019 | 44.37B |
| March 31, 2019 | 43.07B |
| December 31, 2018 | 42.29B |
| September 30, 2018 | 41.73B |
| June 30, 2018 | 41.26B |
| March 31, 2018 | 40.72B |
| Date | Value |
|---|---|
| December 31, 2017 | 40.12B |
| September 30, 2017 | 39.80B |
| June 30, 2017 | 40.02B |
| March 31, 2017 | 39.93B |
| December 31, 2016 | 39.81B |
| September 30, 2016 | 39.91B |
| June 30, 2016 | 39.44B |
| March 31, 2016 | 39.38B |
| December 31, 2015 | 39.50B |
| September 30, 2015 | 39.76B |
| June 30, 2015 | 40.25B |
| March 31, 2015 | 41.40B |
| December 31, 2014 | 42.24B |
| September 30, 2014 | 43.08B |
| June 30, 2014 | 43.55B |
| March 31, 2014 | 43.63B |
| December 31, 2013 | 44.03B |
| September 30, 2013 | 44.45B |
| June 30, 2013 | 44.91B |
| March 31, 2013 | 46.21B |
| December 31, 2012 | 47.27B |
| September 30, 2012 | 47.82B |
| June 30, 2012 | 48.36B |
| March 31, 2012 | 48.20B |
| December 31, 2011 | 48.05B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
36.49B
Minimum
Sep 2020
61.40B
Maximum
Mar 2024
49.73B
Average
47.42B
Median
Revenue (TTM) Benchmarks
| Amgen Inc | 28.19B |
| Johnson & Johnson | 89.66B |
| Eli Lilly and Co | 34.12B |
| Pfizer Inc | 58.50B |
| Moderna Inc | 6.754B |